InvestorsHub Logo
Followers 31
Posts 4733
Boards Moderated 0
Alias Born 08/30/2015

Re: R-Ray post# 61320

Wednesday, 04/18/2018 11:53:44 AM

Wednesday, April 18, 2018 11:53:44 AM

Post# of 77152
It’s at the bottom...this is where Evan clearly states he is paying his own private company with shareholder money. Sorry. That REALLY sucks for shareholders.

“About Easton Pharmaceuticals

Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton has partnered with BMV Medica and together own the exclusive distribution rights in Mexico and Latin America for patented women's diagnostic / treatment products and two generic cancer drugs. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of other drugs and Cannabidiol extracts. Easton has closed on an agreement to acquire 100% of iBliss Inc., a leading e-liquid vapour producer and distributor with international. Easton has closed with Alliance Venture partners towards the cultivation of medical / recreational marijuana in Canada and other aggregate businesses”